eLife · 2018 · 203 citations · 75 references
Life SciencesImmunologyMolecular BiologyChromatin BiologyMolecular VirologyVirologyAntiretroviral TherapyAntiviral TherapyChromatinViral LatencyViral Regulatory ElementsViral TranscriptionEpigenetic Regulation Of LatencyHiv Antiretroviral TherapyHuman Immunodeficiency Virus LatencyLatency ReactivationLatency Reversal TherapyTranscriptional ActivationTranscriptional Control Of LatencyViral Gene Expression In Latency
Human immunodeficiency virus (HIV) infection is currently incurable, due to the persistence of latently infected cells. The ‘shock and kill’ approach to a cure proposes to eliminate this reservoir via transcriptional activation of latent proviruses, enabling direct or indirect killing of infected cells. Currently available latency-reversing agents (LRAs) have however proven ineffective. To understand why, we used a novel HIV reporter strain in primary CD4+ T cells and determined which latently infected cells are reactivatable by current candidate LRAs. Remarkably, none of these agents reactivated more than 5% of cells carrying a latent provirus. Sequencing analysis of reactivatable vs. non-reactivatable populations revealed that the integration sites were distinguishable in terms of chromatin functional states. Our findings challenge the feasibility of ‘shock and kill’, and suggest the need to explore other strategies to control the latent HIV reservoir.
75
Mutation of the mouse klotho gene leads to a syndrome resembling ageing.
PubMed · 1997 · 66.6K citations
Selective inhibition of BET bromodomains
P. Filippakopoulos, Jun Qi, S. Picaud et al. · Nature · 2010 · 4.3K citations · Full text
Domain organization of human chromosomes revealed by mapping of nuclear lamina interactions
Lars Guelen, Ludo Pagie, Émilie Brasset et al. · Nature · 2008 · 2K citations
HIV-1 Integration in the Human Genome Favors Active Genes and Local Hotspots
A. R. W. Schröder, Paul Shinn, Huaming Chen et al. · Cell · 2002 · 1.8K citations · Full text